Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting.
Chung YC, Yang YK, Sulaiman AH, Bergmans P, Tan W. Chung YC, et al. Among authors: sulaiman ah. Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):427-439. doi: 10.9758/cpn.2022.20.3.427. Clin Psychopharmacol Neurosci. 2022. PMID: 35879027 Free PMC article.
Efficacy and safety of paliperidone palmitate 6-monthly long-acting injectable in reduction of relapses in patients with schizophrenia: An Asian subgroup analysis of phase 3, randomized study.
Richarz U, Han J, Bai YM, Yu-Hai Chen E, Chung YC, Jhanwar VG, Kim SW, Sulaiman AH, Knight K, Gopal S. Richarz U, et al. Among authors: sulaiman ah. Medicine (Baltimore). 2023 Aug 25;102(34):e34623. doi: 10.1097/MD.0000000000034623. Medicine (Baltimore). 2023. PMID: 37653768 Free PMC article. Clinical Trial.
Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study).
Hong JP, Malek AZA, Li CT, Paik JW, Sulaiman AH, Madriaga G, Zhuo J, Siggins S, Fu DJ, Ju PC. Hong JP, et al. Among authors: sulaiman ah. Asia Pac Psychiatry. 2023 Dec;15(4):e12548. doi: 10.1111/appy.12548. Epub 2023 Sep 28. Asia Pac Psychiatry. 2023. PMID: 37771084
Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.
Ng CG, Boks MP, Roes KC, Zainal NZ, Sulaiman AH, Tan SB, de Wit NJ. Ng CG, et al. Among authors: sulaiman ah. Eur Neuropsychopharmacol. 2014 Apr;24(4):491-8. doi: 10.1016/j.euroneuro.2014.01.016. Epub 2014 Jan 20. Eur Neuropsychopharmacol. 2014. PMID: 24503279 Clinical Trial.
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2).
Wajs E, Aluisio L, Holder R, Daly EJ, Lane R, Lim P, George JE, Morrison RL, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, Grunfeld J, Jeon HJ, Wilkinson ST, Drevets WC, Singh JB. Wajs E, et al. Among authors: sulaiman ah. J Clin Psychiatry. 2020 Apr 28;81(3):19m12891. doi: 10.4088/JCP.19m12891. J Clin Psychiatry. 2020. PMID: 32316080 Free article. Clinical Trial.
93 results